SCHEMBL4902969

SCHEMBL4902969

CC(CC(CC(CC(CCc1ccccc1)c1ccccc1)c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 4/20 0.46
CYP19A1 P11511 1/20 0.43
TAAR1 Q96RJ0 2/20 0.41
RIPK1 Q13546 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ACP3 P15309 1/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
KCNH2 Q12809 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.39
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895660 1.00 TRPA1 (0.46) TRPA1CYP19A1TAAR1RIPK1ALDH1A1
SCHEMBL21164200 1.00 TRPA1 (0.46) TRPA1CYP19A1TAAR1RIPK1ALDH1A1
SCHEMBL3405992 0.96 TRPA1 (0.49) TRPA1CYP19A1TAAR1RIPK1ALDH1A1
SCHEMBL1538484 0.89 CYP19A1 (0.50) CYP19A1TAAR1ALDH1A1ACP3SLC6A2
SCHEMBL1539110 0.87 CYP19A1 (0.51) CYP19A1TAAR1ALDH1A1ACP3SLC6A2
SCHEMBL13243746 0.84 F2 (0.45) TRPA1TSHRPOLB
SCHEMBL3674520 0.83 TRPA1 (0.59) TRPA1TAAR1RIPK1ALDH1A1SLC6A3
SCHEMBL10014856 0.82 CYP19A1 (0.45) CYP19A1ACP3SLC6A2SLC6A4SLC6A3
SCHEMBL3020929 0.81 SLC6A2 (0.40) CYP19A1TAAR1ALDH1A1ACP3SLC6A2
SCHEMBL13814553 0.81 ALDH1A1 (0.43) TRPA1CYP19A1ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179225-A1 PROCESS AND CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INITIATED ANIONIC CHAIN TRANSFER POLYMERIZATION ALBEMARLE CORP (US) 2025-06-05 US disclosed
EP-3445791-B1 PROCESS AND CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INITIATED ANICONIC CHAIN TRANSFER POLYMERIZATION ALBEMARLE CORP (US) 2025-03-26 EP disclosed
US-12234304-B2 Process and catalyst for hydrogen mediated saline hydride initiated anionic chain transfer polymerization ALBEMARLE CORPORATION (US) 2025-02-25 US disclosed
CN-113061204-B Hydrocarbon soluble salt hydride catalyst and preparation method thereof 雅宝公司 2024-03-22 CN disclosed
EP-4289870-A2 PROCESS AND HYDROCARBON SOLUBLE SALINE HYDRIDE CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INIATED ANIONIC CHAIN TRANSFER POLYMERIZATION AND POLYMER DISTRIBUTION COMPOSITIONS PRODUCED THEREFROM Albemarle Corporation (US) 2023-12-13 EP disclosed
EP-3440120-B1 PROCESS AND HYDROCARBON SOLUBLE SALINE HYDRIDE CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INIATED ANIONIC CHAIN TRANSFER POLYMERIZATION AND POLYMER DISTRIBUTION COMPOSITIONS PRODUCED THEREFROM ALBEMARLE CORP (US) 2023-11-29 EP disclosed
US-20230272185-A1 ADDITIVES FOR FLAME RETARDED POLYOLEFINS ALBEMARLE CORPORATION 2023-08-31 US disclosed
US-11739170-B2 Process and hydrocarbon soluble saline hydride catalyst for hydrogen mediated saline hydride initiated anionic chain transfer polymerization and polymer distribution compositions produced therefrom ALBEMARLE CORPORATION (US) 2023-08-29 US disclosed
US-20230227591-A1 PROCESS AND CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INITIATED ANIONIC CHAIN TRANSFER POLYMERIZATION ALBEMARLE CORPORATION 2023-07-20 US disclosed
EP-4192906-A1 ADDITIVES FOR FLAME RETARDED POLYOLEFINS ALBEMARLE CORPORATION (US) 2023-06-14 EP disclosed
WO-2017184350-A1 PROCESS AND CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INITIATED ANICONIC CHAIN TRANSFER POLYMERIZATION ALBEMARLE CORPORATION (US) 2017-10-26 WO disclosed
WO-2017176740-A1 PROCESS AND HYDROCARBON SOLUBLE SALINE HYDRIDE CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INIATED ANIONIC CHAIN TRANSFER POLYMERIZATION AND POLYMER DISTRIBUTION COMPOSITIONS PRODUCED THEREFROM ALBEMARLE CORPORATION (US) 2017-10-12 WO disclosed
US-8399596-B2 Epoxy resin compositions and process for preparing them BASF AKTIENGESELLSCHAFT (DE) 2013-03-19 US disclosed
US-20080200703-A1 Heterogeneous Ruthenium Catalyst and Method For Hydrogenating a Carboxylic Aromatic Group, in Particular For Producing Core Hydrogenated Bisglycidyl Ether Bisphenols A and F BASF AKTIENGESELLSCHAFT (DE) 2008-08-21 US disclosed
US-20080139728-A1 Epoxy resins from epichlorohydrin, bisphenol A, bisphenol F, 4,4'-isopropylidenedicyclohexanol, and bis(4-hydroxycyclohexyl)methane crosslinked by diamines and triamines; prepared with a ruthenium catalyst on a halogen-free support; transparent protective devices, sports equipment, construction materials BASF AKTIENGESELLSCHAFT (DE) 2008-06-12 US disclosed
US-20070149793-A1 Heterogeneous ruthenium catalyst, nucleus-hydrogenated diglycidyl ether of bisphenols a and f, and method for the production thereof BASF AKTIENGESELLSCHAFT PATENTS, TRADEMARKS AND LICENSES (DE) 2007-06-28 US disclosed
US-20070112210-A1 Heterogeneous ruthenium catalyst, methods for hydrogenating a carbocyclic aromatic group, and nucleus-hydrogenated diglycidyl ether of bisphenols a and f BASF AKTIENGESELLSCHAFT (DE) 2007-05-17 US disclosed
US-6046248-A Biodegradable polymers, the preparation thereof and the use thereof for producing biodegradable moldings BASF AKTIENGESELLSCHAFT (DE) 2000-04-04 US disclosed
US-5936045-A Biodegradable polymers, the preparation thereof, and the use thereof for producing biodegradable moldings BASF AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
US-5817721-A POLYESTER BASF AKTIENGESELLSCHAFT (DE) 1998-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112210-A1 Heterogeneous ruthenium catalyst, methods for hydrogenating a carbocyclic aromatic group, and nucleus-hydrogenated diglycidyl ether of bisphenols a and f HNRNPL, HNRNPH3, HNRNPLL TRPA1 3065/4885CYP19A1 619/4885TAAR1 2347/4885
US-20080200703-A1 Heterogeneous Ruthenium Catalyst and Method For Hydrogenating a Carboxylic Aromatic Group, in Particular For Producing Core Hydrogenated Bisglycidyl Ether Bisphenols A and F BET1, HRH4, HRH3 TRPA1 1230/4885CYP19A1 2295/4885TAAR1 1019/4885
US-20070149793-A1 Heterogeneous ruthenium catalyst, nucleus-hydrogenated diglycidyl ether of bisphenols a and f, and method for the production thereof HNRNPL, HNRNPH3, HNRNPF TRPA1 4109/4885CYP19A1 720/4885TAAR1 4048/4885
US-20080139728-A1 Epoxy resins from epichlorohydrin, bisphenol A, bisphenol F, 4,4'-isopropylidenedicyclohexanol, and bis(4-hydroxycyclohexyl)methane crosslinked by diamines and triamines; prepared with a ruthenium catalyst on a halogen-free support; transparent protective devices, sports equipment, construction materials EED, RAD54L, HPD TRPA1 1798/4885CYP19A1 351/4885TAAR1 1477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.